Skip to main content
    P

    Prestige Brand Holdings Inc (PBH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $48.03
    +1.84 (+3.98%)

    Market Cap: $2.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Prestige Brand Holdings Inc (PBH) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Prestige Brand Holdings (PBH) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Prestige Brand Holdings reported EPS of $1.13, above the $1.06 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    78%(31/40)
    Avg Surprise
    +3.28%
    Streak
    2 Q

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.05
    Range$1.05 - $1.06
    6 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$1.24-15.1%
    60d ago$1.24-15.3%
    30d ago$1.24-15.3%
    7d ago$1.23-14.7%
    Current$1.05
    Revenue Consensus
    $328.02M
    Range$327.53M - $328.30M
    6 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.35
    Range$1.29 - $1.44
    8 analysts
    Revenue Consensus
    $354.88M
    Range$341.15M - $374.12M
    8 analysts

    Next Report

    PBH has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 7.9% below the $1.14 reported for the quarter ended Dec 31, 2025.

    PBH Earnings Call

    The latest PBH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, PBH beat 31, missed 7 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $336.31M, up 22.7% from $274.11M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.13$1.06$1.06 - $1.08+6.60%Beat+31.4%70 up, 1 downNov 5, 2026$336.31M
    Jun 30, 2026$0.98$0.89$0.87 - $0.89+10.11%Beat+3.2%60 up, 3 downAug 6, 2026$265.71M
    Mar 31, 2026$1.23$1.39$1.38 - $1.40-11.51%Miss-6.8%60 up, 1 downMay 13, 2026$281.62M
    Dec 31, 2025$1.14$1.16$1.14 - $1.22-1.72%Miss-6.6%71 up, 1 downFeb 5, 2026$283.44M
    Sep 30, 2025$0.86$0.97$0.97 - $0.97-11.34%Miss-21.1%70 up, 1 downNov 6, 2025$274.11M
    Jun 30, 2025$0.95$1.01N/A-5.94%Miss+5.6%50 up, 2 downAug 7, 2025$249.53M
    Mar 31, 2025$1.32$1.29$1.24 - $1.30+2.33%Beat+29.4%84 up, 2 downMay 8, 2025$296.52M
    Dec 31, 2024$1.22$1.16$1.14 - $1.16+5.17%Beat+15.1%70 up, 5 downFeb 6, 2025$290.32M
    Sep 30, 2024$1.09$1.08$1.08 - $1.10+0.93%Beat+1.9%70 up, 0 downNov 7, 2024$283.79M
    Jun 30, 2024$0.90$0.86$0.86 - $0.86+4.65%Beat-15.1%60 up, 0 downAug 8, 2024$267.14M
    Mar 31, 2024$1.02$1.14$1.14 - $1.14-10.53%Miss-4.7%60 up, 0 downMay 14, 2024$276.99M
    Dec 31, 2023$1.06$1.04$1.04 - $1.05+1.92%Beat+1.9%60 up, 0 downFeb 8, 2024$282.74M
    Sep 30, 2023$1.07$1.07$1.05 - $1.070.00%In line+4.9%60 up, 0 downNov 2, 2023$286.32M
    Jun 30, 2023$1.06$1.01$1.00 - $1.02+4.95%Beat-2.8%51 up, 0 downAug 3, 2023$279.31M
    Mar 31, 2023$1.07$1.04$1.04 - $1.04+2.88%Beat+17.6%60 up, 0 downMay 4, 2023$285.87M
    Dec 31, 2022$1.04$1.01$1.01 - $1.02+2.97%Beat+5.1%60 up, 0 downFeb 2, 2023$275.52M
    Sep 30, 2022$1.02$1.00$0.99 - $1.02+2.00%Beat0.0%60 up, 1 downNov 3, 2022$289.27M
    Jun 30, 2022$1.09$1.04N/A+4.81%Beat-4.4%N/A0 up, 0 downAug 4, 2022$277.06M
    Mar 31, 2022$0.91$0.89$0.86 - $0.92+2.25%Beat+15.2%60 up, 0 downMay 5, 2022$266.94M
    Dec 31, 2021$0.99$0.88$0.88 - $0.89+12.50%Beat+22.2%6N/AFeb 3, 2022$274.47M
    Sep 30, 2021$1.02$0.99$0.97 - $1.00+3.03%Beat+30.8%64 up, 0 downNov 4, 2021$276.23M
    Jun 30, 2021$1.14$0.87$0.86 - $1.14+31.03%Beat+32.6%6N/AAug 5, 2021$269.18M
    Mar 31, 2021$0.79$0.78$0.77 - $0.80+1.28%Beat-3.7%7N/AMay 6, 2021$237.76M
    Dec 31, 2020$0.81$0.77$0.73 - $0.79+5.19%Beat0.0%7N/AFeb 4, 2021$238.79M
    Sep 30, 2020$0.78$0.72$0.70 - $0.74+8.33%Beat+14.7%7N/ANov 5, 2020$237.42M
    Jun 30, 2020$0.86$0.70$0.70 - $0.70+22.86%Beat+32.3%6N/AAug 6, 2020$229.39M
    Mar 31, 2020$0.82$0.74$0.71 - $0.81+10.81%Beat+13.9%6N/AMay 7, 2020$254.00M
    Dec 31, 2019$0.81$0.75$0.73 - $0.78+8.00%Beat+11.0%4N/AFeb 6, 2020$241.55M
    Sep 30, 2019$0.68$0.66$0.64 - $0.67+3.03%Beat+4.6%5N/AOct 31, 2019$238.07M
    Jun 30, 2019$0.65$0.64$0.62 - $0.65+1.56%Beat-4.4%5N/AAug 1, 2019$232.15M
    Mar 31, 2019$0.72$0.70$0.69 - $0.74+2.86%Beat+16.1%5N/AMay 9, 2019N/A
    Dec 31, 2018$0.73$0.72$0.70 - $0.76+1.39%Beat+4.3%5N/AFeb 7, 2019$724.24M
    Sep 30, 2018$0.65$0.63$0.62 - $0.64+3.17%Beat+6.6%5N/ANov 1, 2018$239.36M
    Jun 30, 2018$0.68$0.67$0.65 - $0.68+1.49%Beat+3.0%5N/AAug 2, 2018$253.98M
    Mar 31, 2018$0.62$0.61$0.60 - $0.62+1.64%Beat+14.8%5N/AMay 10, 2018$2.34B
    Dec 31, 2017$0.70$0.70$0.68 - $0.720.00%In line+14.8%6N/AFeb 1, 2018$270.62M
    Sep 30, 2017$0.61$0.66$0.66 - $0.67-7.58%Miss-3.2%5N/ANov 2, 2017$258.03M
    Jun 30, 2017$0.66$0.64$0.61 - $0.66+3.13%Beat+11.9%6N/AAug 3, 2017$256.57M
    Mar 31, 2017$0.54$0.55N/A-1.82%Miss+3.8%N/AN/AMay 11, 2017$240.67M
    Dec 31, 2016$0.61$0.56N/A+8.93%Beat+15.1%N/AN/AFeb 2, 2017$216.76M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Mar 31, 2026 was $4.18, down 7.7% from the year before. It was $2.37 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Mar 31, 2026$4.18-7.7%
    Mar 31, 2025$4.53+7.6%
    Mar 31, 2024$4.21N/A
    Mar 31, 2023$4.22+3.9%
    Mar 31, 2022$4.06+25.3%
    Mar 31, 2021$3.24+9.5%
    Mar 31, 2020$2.96+6.5%
    Mar 31, 2019$2.78+7.3%
    Mar 31, 2018$2.59+9.3%
    Mar 31, 2017$2.37N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,400 words across 10 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20264,35110
    2026Q2Jun 30, 20265,88611
    2026Q1Mar 31, 20264,4618
    2025Q4Dec 31, 20255,3779
    2025Q3Sep 30, 20254,36510
    2025Q2Jun 30, 20253,6067
    2025Q1Mar 31, 20254,63710
    2024Q4Dec 31, 20246,8779

    2026Q3 Earnings Call

    Opening remarks

    Philip Terpolilli Vice President, Investor Relations and Treasury Thanks, operator. And thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President, and CEO, and Christine Sacco, our CFO and COO. On today's call, we'll review our third quarter fiscal 2026 results, discuss our full-year outlook, and then take questions from analysts. The slide presentation accompanying today's call can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the investors link, and then on today's webcast and presentation. Remember, some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures are included in our earnings release and slide presentation. On today's call, management will make forward-looking statements around risks and uncertainties, which are detailed in a complete safe harbor on page two of the slide presentation that accompanies the call. These are important to review and contemplate. Business environment uncertainty remains heightened due to supply chain constraints, high inflation, and geopolitical events, which have numerous potential impacts. This means results could change at any time, and the forecasted impact of risk considerations is the best estimate based on the information available as of today's date. Additional information concerning risk factors and cautionary statements are available in our most recent SEC filings and the most recent company 10-K. And I'll hand it over to our CEO, Ron Lombardi. Ron?

    Ron Lombardi Chairman, President, and CEO Thanks, Phil. Let's begin on slide five. We delivered solid results for the third quarter, which reflected the benefits of our diverse business model and strong financial profile. We are pleased with these results, especially when navigating the challenging consumer backdrop we've seen year to date, which includes consumers changing where they shop in a fluid environment with tariff inflation, a government shutdown, public announcements related to acetaminophen, and more. All of this led to a dynamic environment in Q3 that we successfully managed through. Sales of $283 million were slightly better than forecast. Our diverse customer base allowed us to see solid order trends in our growing channels, which more than offset the impact of other channels that are more affected by the macro issues I just mentioned. Our broad distribution allows us to benefit from changes in consumer shopping habits no matter where they look to buy our trusted and leading brands. Another positive is that we continue to see sequential improvement in Clear Eyes supply for the second quarter in a row. We anticipate further improvements based on actions we've taken that I'll discuss shortly. Moving down the P&L, both gross margin of 55.5% and adjusted EPS of $1.14 were in line with our expectations provided on our second quarter call.

    Frequently Asked Questions About PBH

    When is Prestige Brand Holdings's next earnings date?

    Prestige Brand Holdings's next earnings report is expected for Feb 3, 2027.

    Did PBH beat earnings estimates last quarter?

    Yes. Prestige Brand Holdings reported EPS of $1.13 for the quarter ended Sep 30, 2026, above the $1.06 estimate, a 6.60% surprise.

    What EPS do analysts expect from PBH next quarter?

    The consensus EPS estimate for Prestige Brand Holdings for the quarter ending Dec 31, 2026 is $1.05 from 6 analysts, with estimates from $1.05 to $1.06.

    How often does PBH beat earnings estimates?

    Prestige Brand Holdings beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -0.79%.